[When is a patient with coronary heart disease optimally treated?].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003131:Combined Modality Therapy; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000628:therapy*; D003645:Death, Sudden; D004359:Drug Therapy, Combination; D016027:Heart Transplantation; D006801:Humans; D012151:Resuscitation; D012306:Risk; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D002121:Calcium Channel Blockers
Wann ist ein Patient mit koronarer Herzerkrankung optimal behandelt?